Increased neurokinin-1 receptor availability in temporal lobe epilepsy: A positron emission tomography study using [ 11C]GR205171

Epilepsy Research

Volumn 97, Issue 1-2, 2011, Pages 183-189

  Danfors, Torsten ^a   Åhs, Fredrik ^a   Appel, Lieuwe ^a   Linnman, Clas ^a,b   Fredrikson, Mats ^a   Furmark, Tomas ^a   Kumlien, Eva ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b MCLEAN HOSPITAL   (United States)

Author keywords

Epilepsy; NK1; PET; Substance P; TLE

Indexed keywords

NEUROKININ 1 RECEPTOR; SUBSTANCE P; TRACER; VOFOPITANT;

ADULT; ANTERIOR CINGULATE; ARTICLE; CAUDATE NUCLEUS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; FEMALE; HUMAN; LEFT HEMISPHERE; MALE; NEUROBIOLOGY; NEUROIMAGING; OCCIPITAL LOBE; PARIETAL LOBE; POSITRON EMISSION TOMOGRAPHY; PRIMARY MOTOR CORTEX; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RIGHT HEMISPHERE; TEMPORAL LOBE; TEMPORAL LOBE EPILEPSY; UPREGULATION;

ADULT; CARBON RADIOISOTOPES; EPILEPSY, TEMPORAL LOBE; FEMALE; HUMANS; MALE; MIDDLE AGED; PIPERIDINES; POSITRON-EMISSION TOMOGRAPHY; RECEPTORS, NEUROKININ-1; SEVERITY OF ILLNESS INDEX; SUBSTANCE P; TEMPORAL LOBE; TETRAZOLES; YOUNG ADULT;

EID: 81055156125     PISSN: 09201211     EISSN: 18726844     Source Type: Journal    
DOI: 10.1016/j.eplepsyres.2011.08.006     Document Type: Article

References (31)

1. Bergstrom M., Fasth K.J., Kilpatrick G., Ward P., Cable K.M., Wipperman M.D., Sutherland D.R., Langstrom B. Brain uptake and receptor binding of two [11C]labelled selective high affinity NK1-antagonists, GR203040 and GR205171 - PET studies in rhesus monkey. Neuropharmacology 2000, 39:664-670.
2. Brene S., Lindefors N., Ballarin M., Persson H. Kainic acid-mediated increase of preprotachykinin-A messenger RNA expression in the rat hippocampus and a region-selective attenuation by dexamethasone. Neuroscience 1992, 50:611-618.
3. Chassagnon S., Namer I.J., Armspach J.P., Nehlig A., Kahane P., Kehrli P., Valenti M.P., Hirsch E. SPM analysis of ictal-interictal SPECT in mesial temporal lobe epilepsy: relationships between ictal semiology and perfusion changes. Epilepsy Res. 2009, 85:252-260.
4. Didelot A., Ryvlin P., Lothe A., Merlet I., Hammers A., Mauguiere F. PET imaging of brain 5-HT1A receptors in the preoperative evaluation of temporal lobe epilepsy. Brain 2008, 131:2751-2764.
5. Ebner K., Singewald N. The role of substance P in stress and anxiety responses. Amino Acids 2006, 31:251-272.
6. Englot D.J., Mishra A.M., Mansuripur P.K., Herman P., Hyder F., Blumenfeld H. Remote effects of focal hippocampal seizures on the rat neocortex. J. Neurosci. 2008, 28:9066-9081.
7. Hammers A. Flumazenil positron emission tomography and other ligands for functional imaging. Neuroimaging Clin. N. Am. 2004, 14:537-551.
8. Henriksen G., Willoch F. Imaging of opioid receptors in the central nervous system. Brain 2008, 131:1171-1196.
9. Hietala J., Nyman M.J., Eskola O., Laakso A., Gronroos T., Oikonen V., Bergman J., Haaparanta M., Forsback S., Marjamaki P., Lehikoinen P., Goldberg M., Burns D., Hamill T., Eng W.S., Coimbra A., Hargreaves R., Solin O. Visualization and quantification of neurokinin-1 (NK1) receptors in the human brain. Mol. Imaging Biol. 2005, 7:262-272.
10. Kalinichev M., Bradford A., Bison S., Lucas A., Sartori I., Garbati N., Andreetta F., Bate S., Austin N.E., Jones D.N., Read K.D., Alvaro G., Large C.H. Potentiation of the anticonvulsant efficacy of sodium channel inhibitors by an NK1-receptor antagonist in the rat. Epilepsia 2010, 51:1543-1551.
11. Kumlien E., Hartvig P., Valind S., Oye I., Tedroff J., Langstrom B. NMDA-receptor activity visualized with (S)-[N-methyl-11C]ketamine and positron emission tomography in patients with medial temporal lobe epilepsy. Epilepsia 1999, 40:30-37.
12. Leifer D., Cole D.G., Kowall N.W. Neuropathologic asymmetries in the brain of a patient with a unilateral status epilepticus. J. Neurol. Sci. 1991, 103:127-135.
13. Linnman C., Appel L., Furmark T., Soderlund A., Gordh T., Langstrom B., Fredrikson M. Ventromedial prefrontal neurokinin 1 receptor availability is reduced in chronic pain. Pain 2010, 149:64-70.
14. Liu H., Mazarati A.M., Katsumori H., Sankar R., Wasterlain C.G. Substance P is expressed in hippocampal principal neurons during status epilepticus and plays a critical role in the maintenance of status epilepticus. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:5286-5291.
15. Liu H., Sankar R., Shin D.H., Mazarati A.M., Wasterlain C.G. Patterns of status epilepticus-induced substance P expression during development. Neuroscience 2000, 101:297-304.
16. Lothman E.W., Collins R.C. Kainic acid induced limbic seizures: metabolic, behavioral, electroencephalographic and neuropathological correlates. Brain Res. 1981, 218:299-318.
17. Lothman E.W., Collins R.C., Ferrendelli J.A. Kainic acid-induced limbic seizures: electrophysiologic studies. Neurology 1981, 31:806-812.
18. Lothman E.W., Hatlelid J.M., Zorumski C.F. Functional mapping of limbic seizures originating in the hippocampus: a combined 2-deoxyglucose and electrophysiologic study. Brain Res. 1985, 360:92-100.
19. Magloczky Z. Sprouting in human temporal lobe epilepsy: excitatory pathways and axons of interneurons. Epilepsy Res. 2010, 89:52-59.
20. Michelgard A., Appel L., Pissiota A., Frans O., Langstrom B., Bergstrom M., Fredrikson M. Symptom provocation in specific phobia affects the substance P neurokinin-1 receptor system. Biol. Psychiatry 2007, 61:1002-1006.
21. Nyman M.J., Eskola O., Kajander J., Vahlberg T., Sanabria S., Burns D., Hargreaves R., Solin O., Hietala J. Gender and age affect NK1 receptors in the human brain - a positron emission tomography study with [18F]SPA-RQ. Int. J. Neuropsychopharmacol. 2007, 10:219-229.
22. Patlak C.S., Blasberg R.G., Fenstermacher J.D. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. J. Cereb. Blood Flow Metab. 1983, 3:1-7.
23. Patlak C.S., Blasberg R.G. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. Generalizations. J. Cereb. Blood Flow Metab. 1985, 5:584-590.
24. Pennell P.B. PET: cholinergic neuroreceptor mapping. Adv. Neurol. 2000, 83:157-163.
25. Sakagami M., Takahashi Y., Hoshida T., Mochizuki T., Matsuoka H., Naka H., Fujimiya M., Yoshioka A. Intractable epilepsy: expression of substance P in cortical dysplastic neurons. Pediatr. Int. 2009, 51:418-421.
26. Salmenpera T.M., Symms M.R., Rugg-Gunn F.J., Boulby P.A., Free S.L., Barker G.J., Yousry T.A., Duncan J.S. Evaluation of quantitative magnetic resonance imaging contrasts in MRI-negative refractory focal epilepsy. Epilepsia 2007, 48:229-237.
27. Stacey A.E., Woodhall G.L., Jones R.S. Neurokinin-receptor-mediated depolarization of cortical neurons elicits an increase in glutamate release at excitatory synapses. Eur. J. Neurosci. 2002, 16:1896-1906.
28. Toth K., Wittner L., Urban Z., Doyle W.K., Buzsaki G., Shigemoto R., Freund T.F., Magloczky Z. Morphology and synaptic input of substance P receptor-immunoreactive interneurons in control and epileptic human hippocampus. Neuroscience 2007, 144:495-508.
29. Van Paesschen W., Dupont P., Sunaert S., Goffin K., Van Laere K. The use of SPECT and PET in routine clinical practice in epilepsy. Curr. Opin. Neurol. 2007, 20:194-202.
30. Yakushev I.Y., Dupont E., Buchholz H.G., Tillmanns J., Debus F., Cumming P., Heimann A., Fellgiebel A., Luhmann H.J., Landvogt C., Werhahn K.J., Schreckenberger M., Potschka H., Bartenstein P. In vivo imaging of dopamine receptors in a model of temporal lobe epilepsy. Epilepsia 2010, 51:415-422.
31. Zachrisson O., Lindefors N., Brene S. A tachykinin NK1 receptor antagonist, CP-122,721-1, attenuates kainic acid-induced seizure activity. Brain Res. Mol. Brain Res. 1998, 60:291-295.